Part the Cloud, a program through the Alzheimer's Association, announces a targeted challenge funding program focused on increasing early phase human trials (Phase 1 and Phase 2) of potential therapies tailored to the genetic underpinnings of Alzheimer’s disease and related dementias internationally.
Both non-profit and small for-profit organizations are eligible. Open to International Applicants. Small for-profit organizations must submit documentation of net assets and annual earnings during the letter of intent process as a part of the review process. Not-for-profit organizations must submit documentation verifying status during the letter of intent process. Applications will be accepted from organizations conducting studies around the world. Researchers with full-time staff or faculty appointments are encouraged to apply. Applications from post- doctoral candidates will not be accepted. For questions as to whether an investigator or organization is eligible, please contact the Alzheimer’s Association at grantsapp@alz.org.
Sponsor Institute/Organizations: Alzheimer's Association
Address: 225 N. Michigan Ave. Floor 17 Chicago, IL 60601
Oct 24, 2024
Jan 09, 2025
$1,000,000
5 awards available.
Affiliation: Alzheimer's Association
Address: 225 N. Michigan Ave. Floor 17 Chicago, IL 60601
Website URL: https://www.alz.org/research/for_researchers/grants/types-of-grants/part-the-cloud-translational-gene-targeting
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.